drugset / Trial / NCT00390260

Effect of Rofecoxib and a Narcotic Analgesic to Treat Pain Following Arthroscopic Surgery (0966-179)(COMPLETED)

NCT00390260

Phase 3 Completed 420 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

Study the effect of rofecoxib 50 mg compared to both placebo, and hydrocodone 7.5 mg with acetaminophen 750 mg, to treat moderate to severe pain following arthroscopic knee surgery.

Timeline

Start
2002-02
Primary completion
2003-02
Completion
2003-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 750 mg
Subject hydrocodone bitartrate Unknown 7.5 mg
Subject rofecoxib Small molecule 50 mg

Indications

No indication recorded.